Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor

Springer Science and Business Media LLC - Tập 28 Số 4 - Trang 190-198 - 2015
Nobuyasu Takahashi1, Fumiyo Aoyama1, Jiro Ohuchida2, N. Sameshima3, Yujiro Asada3, Akira Sawaguchi1
1Department of Anatomy, Ultrastructural Cell Biology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
2Surgical Oncology and Regulation of Organ Function, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
3Division of Pathophysiology, Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hruban RH. Pancreatic cancer. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. France: International Agency for Research on Cancer; 2014. p. 413–21.

Iwamura T, Katsuki T, Ide K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Japanese J Cancer Res Gann. 1987;78(1):54–62.

Tsukuma H, Ajiki W, Ioka A, Oshima A. Research Group of Population-Based Cancer Registries of J. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006;36(9):602–7. doi: 10.1093/jjco/hyl068 .

Willett CG, Czito BG, Bendell JC, Ryan DP. Locally advanced pancreatic cancer. J Clin Oncol Offi J Am Soc Clin Oncol. 2005;23(20):4538–44. doi: 10.1200/JCO.2005.23.911 .

Fernandez-del Castillo C, Rattner DW, Warshaw AL. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg. 1995;82(8):1127–9.

Hoffman JP, Willett CG, Cohen SJ. Pancreas cancer: clinical management. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Cutsem EV, editors. Principles and practice of gastrointestinal oncology. 2nd ed. USA: Lippincott Williams & Wilkins; 2008. p. 377–92.

Takahashi N, Aoyama F, Hiyoshi M, Kataoka H, Sawaguchi A. Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater. Int J Oncol. 2014;44(4):1139–45. doi: 10.3892/ijo.2014.2282 .

Sawaguchi A, Aoyama F, Ide S, Suganuma T. Capsule-supporting ring: a new device for resin embedding of glass-mounted specimens. J Microsc. 2009;234(2):113–7. doi: 10.1111/j.1365-2818.2009.03161.x .

Kawano K, Iwamura T, Yamanari H, Seo Y, Suganuma T, Chijiiwa K. Establishment and characterization of a novel human pancreatic cancer cell line (SUIT-4) metastasizing to lymph nodes and lungs in nude mice. Oncology. 2004;66(6):458–67. doi: 10.1159/000079500 .

Kong D, Nishino N, Shibusawa M, Kusano M. Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse. Tissue Cell. 2007;39(4):217–23. doi: 10.1016/j.tice.2007.04.001 .

Frena A. SPan-1 and exocrine pancreatic carcinoma. The clinical role of a new tumor marker. Int J Biol. 2001;16(3):189–97.

Moore PS, Sipos B, Orlandini S, Sorio C, Real FX, Lemoine NR, et al. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 2001;439(6):798–802.

Yamaguchi N, Yamamura Y, Koyama K, Ohtsuji E, Imanishi J, Ashihara T. Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium. Cancer Res. 1990;50(21):7008–14.

Taniguchi S, Iwamura T, Kitamura N, Yamanari H, Kojima A, Hidaka K, et al. Protein-free culture of the human pancreatic cancer cell line, SUIT-2. Hum Cell. 1994;7(4):207–14.

Murphy LO, Abdel-Wahab YH, Wang QJ, Knezetic JA, Permnert J, Larsson J, et al. Receptors and ligands for autocrine growth pathways are up-regulated when pancreatic cancer cells are adapted to serum-free culture. Pancreas. 2001;22(3):293–8.

Sato N, Mizumoto K, Beppu K, Maehara N, Kusumoto M, Nabae T, et al. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential. Cancer Lett. 2000;155(2):153–61.

Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, et al. Characterization of a new primary human pancreatic tumor line. Cancer Invest. 1986;4(1):15–23.

Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, et al. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro. 1982;18(1):24–34.

Ghadially FN. Cell junctions. Ultrastructural pathology of the cell and matrix. 4th ed. MA: Butterworth-Heinemann; 1997. p. 1171–205.

Martinez-Palomo A. Ultrastructural modifications of intercellular junctions in some epithelial tumors. Lab Invest J Tech Methods Pathol. 1970;22(6):605–14.

Colombo F, Trombetta E, Cetrangolo P, Maggioni M, Razini P, De Santis F, et al. Giant lysosomes as a chemotherapy resistance mechanism in hepatocellular carcinoma cells. PLoS One. 2014;9(12):e114787. doi: 10.1371/journal.pone.0114787 .

Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA. 1998;95(25):14821–6.

Weigelt B, Ghajar CM, Bissell MJ. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev. 2014;69–70:42–51. doi: 10.1016/j.addr.2014.01.001 .